Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 81Colorectal Neoplasms 39Stomach Neoplasms 17Carcinoma, Non-Small-Cell Lung 15Liver Neoplasms 14Neoplasms 11Melanoma 11Carcinoma, Renal Cell 11Esophageal Neoplasms 10Pancreatic Neoplasms 9Carcinoma, Transitional Cell 8Breast Neoplasms 8Uterine Cervical Neoplasms 7Triple Negative Breast Neoplasms 7Squamous Cell Carcinoma of Head and Neck 7Small Cell Lung Carcinoma 7Ovarian Neoplasms 7Head and Neck Neoplasms 7Cholangiocarcinoma 7Rectal Neoplasms 6Neoplasm Metastasis 6Colonic Neoplasms 6Urinary Bladder Neoplasms 5Gastrointestinal Neoplasms 5Carcinoma, Merkel Cell 5Biliary Tract Neoplasms 5Prostatic Neoplasms 4Sarcoma 3Lung Neoplasms 3Gallbladder Neoplasms 3

Interventions

pembrolizumab 4Nivolumab 3sintilimab 2Oxaliplatin 2Leucovorin 2Fluorouracil 2Bevacizumab 2vicriviroc 1trifluridine tipiracil drug combination 1spartalizumab 1relatlimab 1regorafenib 1epacadostat 1dabrafenib 1copanlisib 1binimetinib 1atezolizumab 1Tiragolumab 1Irinotecan 1Immune Checkpoint Inhibitors 1Fulvestrant 1E7046 1Cetuximab 1Capecitabine 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Spinocerebellar Degenerations × atezolizumab × Gastrointestinal × Clear all
NCT06784947 2025-10-02

Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer

University of Colorado, Denver

Phase 2 Active not recruiting
13 enrolled
Gastrointestinal

Spinocerebellar Degenerations, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡